Supplementary Tables 1 - 5 from Selection of Personalized Patient Therapy through the Use of Knowledge-Based Computational Models That Identify Tumor-Driving Signal Transduction Pathways

PDF file - 131KB, Wnt target genes and probesets (S1). ER target genes and probesets (S2). Used datasets (S3). Variation in predicted probability of pathway activity between and within cell lines, assessed on dataset E-MTAB-37 (S4). Gene set enrichment analysis results on normal colon samples versus colon adenoma from GSE8671 (S5).